Panthera strengthens management team with appointment of experienced clinical research executive, Jane Restorick

Written by: Mike Wood
Published on: 26 Nov 2019

Panthera Biopartners, an independent SMO (Site Management Organisation) which recently launched its first UK clinical research site, has strengthened its management team with the appointment of Jane Restorick as Chief Commercial Officer. Jane brings with her more than thirty years’ experience in clinical research, most recently as Chief Operating Officer and Chief Patient Officer at Synexus Clinical Research.

During her seventeen years at Synexus, Jane worked across a wide spectrum of clinical research operations, including feasibility, programme management, patient engagement, and global site operations. Since leaving Synexus in 2018, Jane has been a consultant to the Pharmaceutical industry with her own company, Arion Consulting Services.

Dr Ian Smith, co-founder of Panthera Biopartners and founder of Synexus, commented, “I am thrilled that Jane has joined the Panthera team, and to be working with her again. Jane’s experience in clinical research operations is going to be hugely valuable for Panthera as we continue to grow and expand.”

Panthera Biopartners was founded by Dr Ian Smith, founder of Synexus, and Professor John Lyon, previously a global executive at Covance. Panthera opened its first clinical trials site in Preston, Lancashire, UK in November 2019, , and will be initiating its first trials on behalf of  CROs and pharma companies, in the coming months.  Preston is the first of a number of planned sites in the UK and overseas

Panthera will initially recruit patients and run clinical trials in therapy areas which are traditionally managed in primary care including cardiac disease, allergies, migraine, osteoarthritis, osteoporosis, diabetes etc. In 2020 the company is looking to expand into trials for NASH (fatty liver disease) in primary care, and Oncology and Neurology in secondary care.


Panthera Biopartners – an Independent Site Management Organisation

Panthera Biopartners was founded by Dr Ian Smith – founder of Synexus - and Professor John Lyon – previously senior executive at Covance and serial entrepreneur - in July 2019 to provide CROs and pharma clients with services relating to the recruitment and running of clinical trials at its professional clinical trial sites.

The first Panthera site was opened in Preston, Lancashire, UK in October 2019. Further sites are planned to open in Glasgow and Rochdale in early 2020, with more sites planned. Panthera is initially focused on therapeutic areas traditionally managed in primary care.